摘要
目的观察比较乳果糖口服液与妈咪爱颗粒治疗婴儿功能性便秘的疗效。方法选取2016-01~2016-07到该院门诊就诊的功能性便秘患儿46例随机分为观察组(21例)和对照组(25例),观察组口服乳果糖口服液,对照组口服妈咪爱颗粒,比较两组缓解婴儿功能性便秘的疗效。结果观察组显效13例,有效5例,无效3例;对照组显效5例,有效5例,无效15例。观察组疗效优于对照组(Z=-3.309,P=0.001)。结论乳果糖口服液治疗婴儿功能性便秘疗效优于妈咪爱颗粒,对于维持婴儿肠道正常的生理功能有较好的临床疗效。
Objective To compare the clinical effects between fructose oral solution and Medilac-Vita on the treatment of functional constipation in infants. Methods Forty-six infants with functional constipation were selected from the outpatient department during January 2016 and July 2016, and were randomly divided into the observation group and the control group, with 21 cases in the observation group, and 25 cases in the control group. The observa-tion group was treated with fructose, while the control group was treated with Medilac-Vita. The effect of relieving constipation was compared between the two groups. Results In the observation group, 13 cases were markedly effec- tive, 5 cases effective and 3 cases ineffective. In the control group, 5 cases were markedly effective, 5 cases effective and 15 cases ineffective. The curative effect of the observation group was better than that of the control group （Z = -3. 309, P = 0. 001 ）. Conclusion The curative effect of fructose is better than that of Medilac-Vita on the treatment of func- tional constipation in infants.
出处
《中国临床新医学》
2017年第1期69-71,共3页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
